White Paper

A Guide To The Development Of Monoclonal Antibodies (mAb) Purification Platforms

Source: Cytiva
A Guide To The Development Of Monoclonal Antibodies (MAbs) Purifciation Platforms

The use of monoclonal antibodies (MAbs) and MAb conjugates as biopharmaceuticals have increased over the last decade. As a result, more cost-effective, efficient, and flexible process purification solutions are of high priority for MAb manufacturers. Increasing product titers upstream can introduce challenges in downstream purification processes. With increased MAb titers, the cell culture supernatant might contain an elevated number of impurities (e.g., aggregates) that need to be separated from the target molecule.

This white paper is a guide to the development of MAb purification platforms and provides an overview of GE Healthcare’s offering of process chromatography media (resins) and membranes for MAb purification processes. An introduction to high-throughput process development (HTPD) is also given, together with specific case studies on the development purification steps.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: